76 related articles for article (PubMed ID: 17667797)
1. Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk.
Rezk NL; Abdel-Megeed MF; Kashuba AD
Ther Drug Monit; 2007 Aug; 29(4):429-36. PubMed ID: 17667797
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
Shapiro RL; Holland DT; Capparelli E; Lockman S; Thior I; Wester C; Stevens L; Peter T; Essex M; Connor JD; Mirochnick M
J Infect Dis; 2005 Sep; 192(5):720-7. PubMed ID: 16088821
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of RP-HPLC and ultraviolet spectrophotometric methods of analysis for the quantitative estimation of antiretroviral drugs in pharmaceutical dosage forms.
Sarkar M; Khandavilli S; Panchagnula R
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):349-54. PubMed ID: 16330261
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of lamivudine and stavudine in antiretroviral fixed dose combinations by first derivative spectrophotometry and high performance liquid chromatography.
Kapoor N; Khandavilli S; Panchagnula R
J Pharm Biomed Anal; 2006 Jun; 41(3):761-5. PubMed ID: 16464559
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of stavudine, lamivudine and nevirapine by UV spectroscopy, reverse phase HPLC and HPTLC in tablets.
Anbazhagan S; Indumathy N; Shanmugapandiyan P; Sridhar SK
J Pharm Biomed Anal; 2005 Sep; 39(3-4):801-4. PubMed ID: 15950425
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method.
Ramírez-Ramírez A; Sánchez-Serrano E; Loaiza-Flores G; Plazola-Camacho N; Rodríguez-Delgado RG; Figueroa-Damián R; Domínguez-Castro M; López-Martínez M; Flores-García Z; Hernández-Pineda J
PLoS One; 2018; 13(1):e0191236. PubMed ID: 29351333
[TBL] [Abstract][Full Text] [Related]
7. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
9. Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration.
Kunz A; Frank M; Mugenyi K; Kabasinguzi R; Weidenhammer A; Kurowski M; Kloft C; Harms G
J Antimicrob Chemother; 2009 Jan; 63(1):170-7. PubMed ID: 18974161
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
Mills J
N Engl J Med; 2008 Oct; 359(17):1846; author reply 1846-7. PubMed ID: 18949841
[No Abstract] [Full Text] [Related]
11. Studies on antiretroviral drug concentrations in breast milk: validation of a liquid chromatography-tandem mass spectrometric method for the determination of 7 anti-human immunodeficiency virus medications.
Rezk NL; White N; Bridges AS; Abdel-Megeed MF; Mohamed TM; Moselhy SS; Kashuba AD
Ther Drug Monit; 2008 Oct; 30(5):611-9. PubMed ID: 18758393
[TBL] [Abstract][Full Text] [Related]
12. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry.
Pereira AS; Kenney KB; Cohen MS; Hall JE; Eron JJ; Tidwell RR; Dunn JA
J Chromatogr B Biomed Sci Appl; 2000 May; 742(1):173-83. PubMed ID: 10892596
[TBL] [Abstract][Full Text] [Related]
14. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W
J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139
[TBL] [Abstract][Full Text] [Related]
15. Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen.
Pérez H; Vignoles M; Laufer N; Gómez A; Coll P; Lottner J; Rolón M; Salomón H; Cahn P
Antivir Ther; 2008; 13(1):135-9. PubMed ID: 18389908
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
17. HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen.
Marcelin AG; Jarrousse B; Derache A; Ba M; Dakouo ML; Doumbia A; Haidara I; Maïga A; Carcelain G; Peytavin G; Katlama C; Calvez V
AIDS; 2007 Nov; 21(17):2341-3. PubMed ID: 18090283
[TBL] [Abstract][Full Text] [Related]
18. Resistance to antiretrovirals in HIV-infected pregnant women.
Weinberg A; Forster-Harwood J; McFarland EJ; Pappas J; Davies JK; Kinzie K; Barr EA; Paul SM; Salbenblatt CR; Soda E; Vazquez A; Levin MJ
J Clin Virol; 2009 May; 45(1):39-42. PubMed ID: 19329355
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
20. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
